Cite

    Craig Hansen et al.. “Trimethoprim–sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies†.” Pharmacoepidemiology and drug safety, vol. 25, no. 2, 2016, pp. 170–178. http://access.bl.uk/ark:/81055/vdc_100028633086.0x000010